# OnCo record genomefrontier-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/genomefrontier-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "genomefrontier-therapeutics" ;
  schema:name "GenomeFrontier Therapeutics"@en ;
  schema:description "GenomeFrontier Therapeutics makes CAR T-cell therapies, in which a patient's own immune cells are engineered to attack cancer, using a method that does not need a virus to carry the new gene. Its first product targets two markers on B-cell lymphoma cells."@en ;
  schema:url <https://onco.cc/companies/genomefrontier-therapeutics/>, <https://genomefrontier.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://genomefrontier.com/>, <https://genomefrontier.com/pipeline/>, <https://clinicaltrials.gov/study/NCT06703892> ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/car-t-manufacturing-process/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd20/> .